Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -14.04% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 73.06% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -13.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -21.30% |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | 79.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.20% |
| Dec 31, 2025 | -112.46% |
| Sep 30, 2025 | -38.52% |
| Jun 30, 2025 | -20,754.23% |
| Mar 31, 2025 | -116.36% |
| Dec 31, 2024 | -183.98% |
| Sep 30, 2024 | -57.57% |
| Jun 30, 2024 | 100.65% |
| Mar 31, 2024 | -0.26% |
| Dec 31, 2023 | 73.50% |
| Sep 30, 2023 | 64.75% |
| Jun 30, 2023 | 60.73% |
| Mar 31, 2023 | 46.68% |
| Dec 31, 2022 | 2.96% |
| Sep 30, 2022 | -87.78% |
| Jun 30, 2022 | -230.21% |
| Mar 31, 2022 | -94.92% |
| Dec 31, 2021 | -18.37% |
| Sep 30, 2021 | 42.37% |
| Jun 30, 2021 | -1,743.89% |